Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast

1.    Executive Summary

2.    South Korea Proton Therapy Market – Actual & Untapped Market
2.1    South Korea – Proton Therapy Market & Forecast

2.2    South Korea – Untapped Proton Therapy Market

3.    South Korea Proton Therapy Patient – Actual & Untapped Patients
3.1    South Korea – Patient Treated with Proton Therapy Numbers & Forecast

3.2    South Korea – Untapped Patients for Proton Therapy

4.    South Korea – List of Proton Therapy Centers

5.    South Korea – Proton Therapy Treated Patients by Centers
5.1    Ilsan, Seoul Proton Therapy Center

5.2    Seoul (Samsung PTC) Proton Therapy Center

6.    Proton Therapy – Reimbursement Policies
6.1    Proton Therapy Reimbursement Policies for Patients

6.2    Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

7.    Components of a Standard Proton Therapy Center
7.1    Proton Accelerator
7.1.1    Synchrotrons (example: LLUMC at Loma Linda) 
7.1.2    Cyclotrons (example: MGH Boston) 
7.1.3    Synchrocyclotrons (examples: Orsay, Uppsala) 
7.1.4    Linacs (Rome) 
7.1.5    H-minus Synchrotrons
7.1.6    Separated Sector Cyclotrons
7.1.7    Super-conducting Cyclotrons
7.1.8    Fast Cycling Synchrotron

7.2    Beam Transport System

7.3    Beam Delivery System
7.3.1    The Passive Scattering Technique
7.3.2    Beam Scanning

7.4    Nozzle
7.4.1    Single Scattering
7.4.2    Double Scattering
7.4.3    Uniform Scanning Nozzle
7.4.4    Pencil Scanning Nozzle

7.5    Treatment Planning System

7.6    Image Viewers

7.7    Patient Positioning System (PPS) 

7.8    Human Resource

8.    Global Proton Therapy - Company Analysis (2010-2021) 
8.1    IBA Proton Therapy
8.1.1    Sales Analysis

8.2    Varian Medical Systems
8.2.1    Sales Analysis

8.3    Elekta
8.3.1    Sales Analysis

9.    Proton Therapy – Driving Factors
9.1    Technology Advancement

9.2    Growing Incidence of Cancer Patients in South Korea

10.    Proton Therapy – Challenges
10.1    Requires Huge Investment

10.2    Operations Challenges

List of Figures

Figure 2 1: South Korea – Proton Therapy Market (Million US$), 2009 – 2016
Figure 2 2: South Korea – Forecast for Proton Therapy Market (Million US$), 2017 – 2021
Figure 2 3: South Korea – Untapped Proton Therapy Market (Million US$), 2009 – 2016
Figure 2 4: South Korea – Forecast for Untapped Proton Therapy Market (Million US$), 2017 – 2021

Figure 3 1: South Korea – Patient Treated with Proton Therapy (Number), 2009 – 2016
Figure 3 2: South Korea – Forecast for Patient Treated with Proton Therapy (Number), 2017 – 2021
Figure 3 3: South Korea – Untapped Patient for Proton Therapy (Number), 2009 – 2016
Figure 3 4: South Korea – Forecast for Untapped Patient for Proton Therapy (Number), 2017 – 2021

Figure 8 1: Global – IBA Proton Therapy Sales (Million US$), 2010 – 2016
Figure 8 2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2017 – 2021
Figure 8 3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2010 – 2016
Figure 8 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 – 2021
Figure 8 5: Global – Elekta Radiation Technology Sales (Million US$), 2010 – 2016
Figure 8 6: Global – Forecast for Elekta Radiation Technology Sales (Million US$), 2017 – 2021

Figure 9 1: South Korea– Number of Patient Diagnosed With Cancer (Thousand), 2009 – 2016
Figure 9 2: South Korea – Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2017 – 2021

List of Tables

Table 4 1: South Korea – Proton Therapy Facilities in Operation and Under-Construction

Table 5 1: South Korea – KNCC Ilsan Proton Therapy Center with Patients Treated (Number), 2008 – 2015
Table 5 2: South Korea – Seoul (Samsung PTC) Proton Therapy Center with Patients Treated (Number), 2015